The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry
Abstract
OBJECTIVE: To analyze seizure control and treatment in pregnant women with epilepsy. METHODS: Seizure control and treatment were recorded prospectively in 1,956 pregnancies of 1,882 women with epilepsy participating in EURAP, an international antiepileptic drugs (AEDs) and pregnancy registry. RESULTS: Of all cases, 58.3% were seizure-free throughout pregnancy. Occurrence of any seizures was associated with localization-related epilepsy (OR: 2.5; 1.7 to 3.9) and polytherapy (OR: 9.0; 5.6 to 14.8) and for tonic-clonic seizures, with oxcarbazepine monotherapy (OR: 5.4; 1.6 to 17.1). Using first trimester as reference, seizure control remained unchanged throughout pregnancy in 63.6%, 92.7% of whom were seizure-free during the entire pregnancy. For those with a change in seizure frequency, 17.3% had an increase and 15.9% a decrease. Seizures occurred during delivery in 60 pregnancies (3.5%), more commonly in women with seizures during pregnancy (OR: 4.8; 2.3 to 10.0). There were 36 cases of status epilepticus (12 convulsive), which resulted in stillbirth in one case but no cases of miscarriage or maternal mortality. AED treatment remained unchanged in 62.7% of the pregnancies. The number or dosage of AEDs were more often increased in pregnancies with seizures (OR: 3.6; 2.8 to 4.7) and with monotherapy with lamotrigine (OR: 3.8; 2.1 to 6.9) or oxcarbazepine (OR: 3.7; 1.1 to 12.9). CONCLUSIONS: The majority of patients with epilepsy maintain seizure control during pregnancy. The apparently higher risk of seizures among women treated with oxcarbazepine and the more frequent increases in drug load in the oxcarbazepine and lamotrigine cohorts prompts further studies on relationships with pharmacokinetic changes. Risks associated with status epilepticus appear to be lower than previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
Lamotrigine and the risk of malformations in pregnancy
Cunnington, M., Tennis, P., & the International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2005) · Neurology · doi:10.1212/01.wnl.0000154515.94346.89 · Cited by 348
Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During Lactation
Ohman, I., Vitols, S., & Tomson, T. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00232.x · Cited by 295
Lamotrigine clearance during pregnancy
Tran, T. A., Leppik, I. E., Blesi, K., Sathanandan, S. T., & Remmel, R. (2002) · Neurology · doi:10.1212/wnl.59.2.251 · Cited by 241
Clinical Pharmacokinetics of Oxcarbazepine
May, T. W., Korn-Merker, E., & Rambeck, B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342120-00002 · Cited by 224
The impact of pregnancy and childbirth on the metabolism of lamotrigine
Pennell, P. B., Newport, D. J., Stowe, Z. N., Helmers, S. L., Montgomery, J. Q., & Henry, T. R. (2004) · Neurology · doi:10.1212/01.wnl.0000103286.47129.f8 · Cited by 223
Epilepsy and Pregnancy: A Study of 153 Pregnancies in 59 Patients
Knight, A. H., & Rhind, E. G. (1975) · Epilepsia · doi:10.1111/j.1528-1157.1975.tb04726.x · Cited by 209
Gestation-induced changes in lamotrigine pharmacokinetics: A monotherapy study
de Haan, G. J., Edelbroek, P., Segers, J., Engelsman, M., Lindhout, D., Dévilé-Notschaele, M., & Augustijn, P. (2004) · Neurology · doi:10.1212/01.wnl.0000133213.10244.fd · Cited by 197
Change of seizure frequency in pregnant epileptic women.
Schmidt, D., Canger, R., Avanzini, G., Battino, D., Cusi, C., Beck-Mannagetta, G., Koch, S., Rating, D., & Janz, D. (1983) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.8.751 · Cited by 182
Cited by
Meador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.022 · Cited by 400
Teratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 271
Antiepileptic drugs and pregnancy outcomes
Wlodarczyk, B. J., Palacios, A. M., George, T. M., & Finnell, R. H. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35438 · Cited by 138
Antiepileptic drugs in women with epilepsy during pregnancy
Gedzelman, E., & Meador, K. J. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098611433192 · Cited by 57
Metadata
- Authors
- The EURAP Study Group
- Venue
- Neurology
- Published
- 2006-02-14
- Volume
- 66
- Issue
- 3
- Pages
- 354-360
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2921007674
- Cited by
- 331
- References
- 19
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry. https://app.cochat.ai/papers/10.1212/01.wnl.0000195888.51845.80
- The paper
- The EURAP Study Group. (2006). Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry. Neurology. https://doi.org/10.1212/01.wnl.0000195888.51845.80
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.